# Fiagon AG Medical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fiagon-ag-medical-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Berlin, Germany
- Website: www.fiagon.com
- Latest round: Series C (Dec 31, 2015)
- Investors on record: 1

## About

Fiagon AG Medical Technologies delivers innovative medical solutions focused on patient registration and navigation systems for the ENT surgical market, enhancing surgical efficiency and precision through advanced technology.Fiagon AG Medical Technologies, founded in 2007, operates out of Berlin, Germany, specializing in navigation systems for ENT surgeries. The company's latest significant business change was its acquisition by Intersect ENT Inc. on September 15, 2020, for USD 60 mn. CEO Sven Schmole leads the company, which has successfully completed a total of 4 deals.Fiagon specializes in advanced medical solutions for patient registration and navigation systems, primarily within the ENT (ear, nose, and throat) surgical market. The company’s flagship product, the VirtuEye, enables contactless patient registration in under one minute, significantly enhancing the user experience for healthcare professionals. Utilizing an electromagnetic navigation system, Fiagon's tools ensure that both complex and routine surgeries are executed with precision and efficiency. The company’s instruments are designed to adapt to individual patient anatomies, facilitating accurate navigation while also incorporating multifunctional capabilities such as suction and tactile feedback. Fiagon’s products are marketed to hospitals and surgical centers in various global markets, including Europe and North America, catering to a diverse client base of medical professionals who prioritize innovation and reliability in surgical procedures.Fiagon's revenue model primarily consists of direct sales to healthcare institutions, where transactions involve the purchase of their navigation instruments and associated services. The company engages in B2B relationships with hospitals and surgical centers, providing tailored solutions that enhance surgical outcomes. Transactions typically encompass the acquisition of flagship products like the VirtuEye, along with necessary accessories, potentially bundled into comprehensive packages to meet specific client needs. Pricing structures are designed to reflect the value and capabilities of their advanced navigation systems, aiming to support healthcare providers in efficient and effective surgical procedures. Additionally, ongoing support and training services may be included to ensure optimal utilization of Fiagon’s technology in clinical settings.Fiagon AG Medical Technologies plans to utilize its recent acquisition funding to further develop and launch new products targeted at improving surgical navigation and patient registration systems, with specific plans for new features expected to roll out in late 2021. The company is also looking to expand into additional European markets and North America by 2022, leveraging the resources from the USD 60 mn acquisition deal to enhance its product offerings and market presence.

## Funding rounds

- Series C, Dec 31, 2015 — Cascara Ventures
- Series B, Nov 20, 2012 — Cascara Ventures

## Investors

- Cascara Ventures (https://capitalatlas.ai/funds/cascara-ventures) — Series B, Series C